Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Clinical trial NCT01487096 · COMPLETED

Trial details

NCT number: NCT01487096
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2001-04-01
Primary completion: 2003-03-01
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.